Health Care Technology
Company Overview of MedAvante, Inc.
MedAvante, Inc. provides technology-enabled signal detection solutions in clinical trials of treatments for central nervous system disorders worldwide. Its solutions include Virgil Investigative Study Platform for site-based assessments; and MedAvante Central Ratings for live assessments by remote central clinicians. The company also provides scientific risk reduction services, such as rater qualification and training; central review, a monitoring service in which calibrated clinicians review selected assessments that were administered by site raters; and remote ratings, a customized solution that offers sponsors protection against bias and variability. MedAvante, Inc. was formerly known as ...
100 American Metro Boulevard
Hamilton, NJ 08619
Founded in 2002
Key Executives for MedAvante, Inc.
Co-Founder and Chief Executive Officer
Senior Vice President of Global Operations
Senior Vice President of Global Science
Compensation as of Fiscal Year 2015.
MedAvante, Inc. Key Developments
Cerecor Inc. Selects MedAvante, Inc.'s MedAvante Central Ratings For Investigational MDD Study
Dec 2 13
MedAvante, Inc. announced that biopharmaceutical company Cerecor Inc. will use MedAvante Central Ratings in the phase 2 clinical study of CERC-301, an investigational drug intended for the adjunctive treatment of subjects with major depressive disorder (MDD) who have not adequately responded to their current therapy and report recent suicidal ideation.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 22, 2015
Most Searched Private Companies
Sponsored Financial Commentaries